SCHEMBL3562390

SCHEMBL3562390

Cc1ccc(S(=O)(=O)Nc2cccc(CCc3cccc(C(=O)O)c3)c2)cc1

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.62
TCF4 P15884 1/20 0.60
CTNNB1 P35222 1/20 0.60
ALDH1A1 P00352 1/20 0.58
KDM1A O60341 2/20 0.57
SLC16A3 O15427 2/20 0.56
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
HTR6 P50406 4/20 0.55
AKR1C3 P42330 2/20 0.54
LIMK1 P53667 1/20 0.54
LIMK2 P53671 1/20 0.54
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA9 Q16790 1/20 0.54
MAOA P21397 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3556021 0.92 KDM1A (0.59) POLBTCF4CTNNB1ALDH1A1KDM1A
SCHEMBL3554962 0.92 ALDH1A1 (0.64) POLBTCF4CTNNB1ALDH1A1KDM1A
SCHEMBL3558114 0.91 POLB (0.67) POLBALDH1A1SLC16A3MEN1KMT2A
SCHEMBL3553555 0.90 HTR6 (0.67) POLBSLC16A3MEN1KMT2AHTR6
SCHEMBL3561858 0.89 MEN1 (0.65) POLBALDH1A1SLC16A3MEN1KMT2A
SCHEMBL3555895 0.89 POLB (0.61) POLBTCF4CTNNB1ALDH1A1SLC16A3
SCHEMBL3558666 0.89 CA12 (0.61) POLBALDH1A1SLC16A3MEN1KMT2A
SCHEMBL11025715 0.88 POLB (0.78) POLBTCF4CTNNB1ALDH1A1MEN1
SCHEMBL3555622 0.88 SLC16A3 (0.72) POLBALDH1A1SLC16A3MEN1KMT2A
SCHEMBL3564982 0.88 POLB (0.74) POLBALDH1A1SLC16A3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US claimed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US claimed
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US disclosed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes SLC5A1, ALDH7A1, ASS1 POLB 3962/4885TCF4 2012/4885CTNNB1 1509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.